News > Oral Anti-Covid Drug Molnupiravir Has Major Safety Concerns, Says ICMR Chief

Oral Anti-Covid Drug Molnupiravir Has Major Safety Concerns, Says ICMR Chief

Molnupiravir, the first oral anti-Covid drug, has major safety concerns, said the head of the Indian Council of Medical Research (ICMR) on Wednesday. The pill was approved for emergency use in the country by the Drugs Controller General of India (DCGI) in the last week of December.

Thirteen Indian pharmaceutical companies, including Cipla, Sun Pharma and Dr Reddy’s Laboratories, are manufacturing the drug.